303 related articles for article (PubMed ID: 15168026)
1. Targeting multiple signal transduction pathways through inhibition of Hsp90.
Zhang H; Burrows F
J Mol Med (Berl); 2004 Aug; 82(8):488-99. PubMed ID: 15168026
[TBL] [Abstract][Full Text] [Related]
2. Update on Hsp90 inhibitors in clinical trial.
Kim YS; Alarcon SV; Lee S; Lee MJ; Giaccone G; Neckers L; Trepel JB
Curr Top Med Chem; 2009; 9(15):1479-92. PubMed ID: 19860730
[TBL] [Abstract][Full Text] [Related]
3. Selective Inhibition of the Hsp90α Isoform.
Mishra SJ; Khandelwal A; Banerjee M; Balch M; Peng S; Davis RE; Merfeld T; Munthali V; Deng J; Matts RL; Blagg BSJ
Angew Chem Int Ed Engl; 2021 May; 60(19):10547-10551. PubMed ID: 33621416
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity.
Pinzi L; Foschi F; Christodoulou MS; Passarella D; Rastelli G
ChemistryOpen; 2021 Dec; 10(12):1177-1185. PubMed ID: 34633754
[TBL] [Abstract][Full Text] [Related]
5. HSP90 and the chaperoning of cancer.
Whitesell L; Lindquist SL
Nat Rev Cancer; 2005 Oct; 5(10):761-72. PubMed ID: 16175177
[TBL] [Abstract][Full Text] [Related]
6. Revealing Propolis Potential Activity on Inhibiting Estrogen Receptor and Heat Shock Protein 90 Overexpressed in Breast Cancer by Bioinformatics Approaches.
Simanjuntak MV; Jauhar MM; Syaifie PH; Arda AG; Mardliyati E; Shalannanda W; Hermanto BR; Anshori I
Bioinform Biol Insights; 2024; 18():11779322231224187. PubMed ID: 38274992
[TBL] [Abstract][Full Text] [Related]
7. Study of interaction energies between residues of the active site of Hsp90 and geldanamycin analogues using quantum mechanics/molecular mechanics methods.
Vivas-Reyes R; Morales-Bayuelo A; Gueto C; Drosos JC; Márquez Lázaro J; Baldiris R; Ahumedo M; Vivas-Gomez C; Aparicio D
F1000Res; 2019; 8():2040. PubMed ID: 37767457
[No Abstract] [Full Text] [Related]
8. Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice.
Youssef ME; Cavalu S; Hasan AM; Yahya G; Abd-Eldayem MA; Saber S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902446
[TBL] [Abstract][Full Text] [Related]
9. GA-Mediated Disruption of RGA/BZR1 Complex Requires HSP90 to Promote Hypocotyl Elongation.
Plitsi PK; Samakovli D; Roka L; Rampou A; Panagiotopoulos K; Koudounas K; Isaioglou I; Haralampidis K; Rigas S; Hatzopoulos P; Milioni D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613530
[TBL] [Abstract][Full Text] [Related]
10. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions.
Alrhmoun S; Sennikov S
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551661
[TBL] [Abstract][Full Text] [Related]
11. Recent advances toward the development of Hsp90 C-terminal inhibitors.
Amatya E; Blagg BSJ
Bioorg Med Chem Lett; 2023 Jan; 80():129111. PubMed ID: 36549397
[TBL] [Abstract][Full Text] [Related]
12. Exploring breast cancer exosomes for novel biomarkers of potential diagnostic and prognostic importance.
Alagundagi DB; Ghate SD; Rajendra VKJ; Gollapalli P; Shetty VV; D'Souza C; Shetty P; Patil P
3 Biotech; 2023 Jan; 13(1):7. PubMed ID: 36532861
[TBL] [Abstract][Full Text] [Related]
13. HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review).
Li ZN; Luo Y
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36367182
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Ubiquitin E3 Ligases (
Sabour Takanlou L; Cecener G; Sabour Takanlou M; Ozturk Nazlioglu H; Tezcan Unlu H; Isik O; Egeli U; Tunca B; Cubukcu E; Tolunay S; Gokgoz MS
Iran J Public Health; 2022 Aug; 51(8):1836-1846. PubMed ID: 36249118
[TBL] [Abstract][Full Text] [Related]
15. Promastigote-to-Amastigote Conversion in
Clos J; Grünebast J; Holm M
Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145483
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Liposomal Diallyl Disulfide and Oxaliplatin on Proliferation of Colorectal Cancer Cells: In Vitro and In Silico Analysis.
Alrumaihi F; Khan MA; Babiker AY; Alsaweed M; Azam F; Allemailem KS; Almatroudi AA; Ahamad SR; AlSuhaymi N; Alsugoor MH; Algefary AN; Khan A
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213970
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1
Larghi EL; Bruneau A; Sauvage F; Alami M; Vergnaud-Gauduchon J; Messaoudi S
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056725
[TBL] [Abstract][Full Text] [Related]
18. Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers.
Gutierrez M; Guo R; Giaccone G; Liu SV; Hao Z; Hilton C; Hinson JM; Kris MG; Orlemans EO; Drilon A
Lung Cancer; 2021 Dec; 162():23-28. PubMed ID: 34655925
[TBL] [Abstract][Full Text] [Related]
19. Differential STAT gene expressions of Penaeus monodon and Macrobrachium rosenbergii in response to white spot syndrome virus (WSSV) and bacterial infections: Additional insight into genetic variations and transcriptomic highlights.
Soo TCC; Bhassu S
PLoS One; 2021; 16(10):e0258655. PubMed ID: 34653229
[TBL] [Abstract][Full Text] [Related]
20. Role of HSP90 in Cancer.
Birbo B; Madu EE; Madu CO; Jain A; Lu Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
